Lite Strategy, Inc.
LITSHealthcare|Biotechnology|US
$1.02
+0.05 (+4.93%)
DCF Value
$0.16
Tangible Book / Share
$1.71
Cash / Share
$0.13
Financials
Financial Snapshot
Market Cap
$31.0M
Enterprise Value
$26.7M
Revenue (TTM)
$0.00
Net Income (TTM)
-$51.5M
Cash & Investments
$4.3M
Net Cash
$4.3M
Free Cash Flow (TTM)
-$6.8M
Operating CF (TTM)
-$6.8M
Debt/Equity
0.00
Cash Runway & Burn Rate
Cash on Hand
$4.3M
Quarterly Burn
$1.7M
Monthly Burn
$565.8K
Est. Runway
~2.5 quarters
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $53.6M | $102.7M | $74.5M | $182.6M | $153.4M | $153.3M | $100.7M | $38.3M | $18.0M | $5.7M | $4.3M | |
| Operating Cash Flow | $3.5M | -$21.0M | -$29.4M | $34.3M | -$32.0M | -$48.7M | -$52.5M | -$50.5M | -$20.8M | -$9.1M | -$6.8M | |
| Free Cash Flow | $3.4M | -$21.0M | -$29.6M | $33.4M | -$32.7M | -$49.2M | -$52.5M | -$50.5M | -$20.8M | -$9.1M | -$6.8M | |
| Capital Expenditure | -$51.0K | $0.00 | -$217.0K | -$894.0K | -$708.0K | -$479.0K | -$35.0K | -$7.0K | $0.00 | $0.00 | $0.00 | |
| Financing Cash Flow | $4.2M | $70.2M | $1.4M | $74.8M | $3.5M | $49.1M | -$40.0K | -$11.9M | $0.00 | $91.9M | -$7.1M |
R&D Spending
R&D (TTM)
$134.0K
R&D Intensity
—
R&D Growth vs Prior
+9.8%
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.2M | $1.6M | $4.9M | $28.9M | $34.8M | $40.7M | $48.8M | $65.3M | $0.00 | $0.00 | $0.00 | |
| R&D Expense | $7.2M | $17.0M | $32.3M | $34.1M | $69.4M | $85.6M | $52.5M | $16.6M | $3.9M | $122.0K | $134.0K | |
| R&D % of Revenue | 31.1% | 1050.4% | 657.2% | 117.8% | 199.4% | 210.4% | 107.4% | 25.4% | — | — | — | |
| SG&A | $8.6M | $9.8M | $14.6M | $16.7M | $24.4M | $30.5M | $33.1M | $23.3M | $13.5M | $12.1M | $11.3M |
Income Statement
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.2M | $1.6M | $4.9M | $28.9M | $34.8M | $40.7M | $48.8M | $65.3M | $0.00 | $0.00 | $0.00 | |
| Cost of Revenue | $5.0M | $3.4M | $4.3M | $2.7M | $1.4M | $0.00 | $0.00 | $0.00 | $368.0K | $0.00 | $0.00 | |
| Gross Profit | $18.2M | -$1.8M | $652.0K | $26.2M | $33.4M | $40.7M | $48.8M | $65.3M | -$368.0K | $0.00 | $0.00 | |
| R&D | $7.2M | $17.0M | $32.3M | $34.1M | $69.4M | $85.6M | $52.5M | $16.6M | $3.9M | $122.0K | $134.0K | |
| SG&A | $8.6M | $9.8M | $14.6M | $16.7M | $24.4M | $30.5M | $33.1M | $23.3M | $13.5M | $12.1M | $11.3M | |
| Operating Income | $2.4M | -$28.6M | -$46.2M | -$24.5M | -$60.4M | -$75.5M | -$36.8M | $14.5M | -$17.5M | -$12.3M | $5.5M | |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Pretax Income | $2.7M | -$40.1M | -$16.8M | -$46.0M | -$41.3M | -$54.5M | -$31.8M | $17.8M | -$15.9M | -$71.2M | -$51.5M | |
| Net Income | $2.7M | -$40.1M | -$16.8M | -$46.0M | -$41.3M | -$54.5M | -$31.8M | $17.8M | -$15.9M | -$71.2M | -$51.5M | |
| EPS (Diluted) | 1.40 | -19.40 | -15.09 | -10.36 | -12.00 | -9.99 | -4.78 | 2.67 | -2.39 | -2.06 | -8.08 | |
| EBITDA | $2.5M | -$28.5M | -$46.2M | -$24.4M | -$41.0M | -$75.2M | -$36.4M | $25.8M | -$17.1M | -$12.3M | $5.5M | |
| Shares Out. (M) | 1.85 | 2.07 | 3.62 | 4.55 | 5.72 | 6.26 | 6.66 | 6.66 | 6.66 | 34.56 | 33.18 |
Balance Sheet
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.5M | $13.3M | $9.6M | $12.3M | $8.5M | $15.7M | $16.9M | $3.7M | $18.0M | $5.7M | $4.3M | |
| Short-Term Investments | $45.1M | $89.4M | $64.9M | $170.3M | $144.9M | $137.5M | $83.8M | $34.6M | $0.00 | $0.00 | $0.00 | |
| Total Current Assets | $55.3M | $104.3M | $82.2M | $208.6M | $164.8M | $167.1M | $107.5M | $40.8M | $18.3M | $6.1M | $6.2M | |
| Total Assets | $55.7M | $104.7M | $82.7M | $209.7M | $174.1M | $177.8M | $120.8M | $41.4M | $18.3M | $42.7M | $58.4M | |
| Total Current Liabilities | $4.9M | $7.9M | $14.3M | $13.8M | $20.2M | $24.4M | $20.3M | $8.4M | $1.4M | $1.1M | $1.7M | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Liabilities | $4.9M | $54.2M | $34.7M | $132.7M | $124.6M | $125.4M | $96.2M | $8.4M | $1.4M | $1.1M | $1.7M | |
| Stockholders' Equity | $50.8M | $50.5M | $47.9M | $77.1M | $49.5M | $52.4M | $24.6M | $33.0M | $16.9M | $41.6M | $56.7M | |
| Retained Earnings | -$174.3M | -$214.4M | -$231.2M | -$278.4M | -$319.7M | -$374.2M | -$406.0M | -$388.2M | -$404.2M | -$475.3M | -$459.3M |
Cash Flow Statement
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.5M | -$21.0M | -$29.4M | $34.3M | -$32.0M | -$48.7M | -$52.5M | -$50.5M | -$20.8M | -$9.1M | -$6.8M | |
| Capital Expenditure | -$51.0K | $0.00 | -$217.0K | -$894.0K | -$708.0K | -$479.0K | -$35.0K | -$7.0K | $0.00 | $0.00 | $0.00 | |
| Free Cash Flow | $3.4M | -$21.0M | -$29.6M | $33.4M | -$32.7M | -$49.2M | -$52.5M | -$50.5M | -$20.8M | -$9.1M | -$6.8M | |
| Investing Cash Flow | -$10.1M | -$44.3M | $24.3M | -$106.3M | $24.7M | $6.9M | $53.7M | $49.1M | $35.1M | -$95.1M | $8.0M | |
| Financing Cash Flow | $4.2M | $70.2M | $1.4M | $74.8M | $3.5M | $49.1M | -$40.0K | -$11.9M | $0.00 | $91.9M | -$7.1M | |
| Issuance of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $3.5M | $52.3M | $0.00 | $0.00 | $0.00 | $96.8M | $0.00 | |
| Repurchase of Stock | $0.00 | -$267.0K | -$324.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$4.9M | -$7.3M | |
| Net Debt Issuance | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $2.3M | $3.2M | $6.6M | $6.8M | $0.00 | $8.3M | $3.6M | $2.3M | -$144.0K | $0.00 | $623.0K | |
| Net Change in Cash | -$2.4M | $4.9M | -$3.7M | $2.7M | -$3.8M | $7.2M | $1.2M | -$13.2M | $14.3M | -$12.3M | -$5.8M |
Dilution Tracker
Shares outstanding grew 503.8% over 5 years — significant dilution
Shares Outstanding
30M
5-Year Share Growth
+503.8%
Stock Issuance (TTM)
$0.00
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 1.85 | 2.07 | 3.62 | 4.55 | 5.72 | 6.26 | 6.66 | 6.66 | 6.66 | 34.56 | 33.18 | |
| Change vs Prior % | — | 12.2% | 74.7% | 25.8% | 25.7% | 9.3% | 6.5% | 0.0% | 0.0% | 418.7% | -4.0% | |
| Stock Issuance | $0.00 | $0.00 | $0.00 | $0.00 | $3.5M | $52.3M | $0.00 | $0.00 | $0.00 | $96.8M | $0.00 | |
| Stock Repurchase | $0.00 | -$267.0K | -$324.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$4.9M | -$7.3M | |
| Stock Based Comp. | $2.3M | $3.2M | $6.6M | $6.8M | $0.00 | $8.3M | $3.6M | $2.3M | -$144.0K | $0.00 | $623.0K |
Margins & Profitability
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 78.5% | -108.6% | 13.3% | 90.8% | 96.0% | 100.0% | 100.0% | 100.0% | — | — | — | |
| Operating Margin % | 10.3% | -1762.4% | -940.9% | -84.9% | -173.7% | -185.5% | -75.3% | 22.3% | — | — | — | |
| Net Margin % | 11.5% | -2470.3% | -342.2% | -159.2% | -118.7% | -133.8% | -65.2% | 27.2% | — | — | — | |
| EBITDA Margin % | 10.6% | -1759.1% | -939.3% | -84.5% | -117.9% | -184.7% | -74.5% | 39.5% | — | — | — | |
| FCF Margin % | 14.8% | -1296.9% | -603.1% | 115.4% | -93.9% | -121.0% | -107.6% | -77.3% | — | — | — | |
| ROE % | 5.3% | -79.4% | -35.1% | -59.7% | -83.5% | -103.9% | -129.3% | 53.8% | -94.2% | -170.9% | -86.9% | |
| ROA % | 4.8% | -38.3% | -20.3% | -21.9% | -23.7% | -30.6% | -26.4% | 43.0% | -87.2% | -166.7% | -88.2% | |
| ROIC % | 4.7% | -29.5% | -67.6% | -12.5% | -39.0% | -48.9% | -36.1% | 44.0% | -103.1% | -29.5% | 9.6% | |
| R&D / Revenue % | 31.1% | 1050.4% | 657.2% | 117.8% | 199.4% | 210.4% | 107.4% | 25.4% | — | — | — |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0% | -93.0% | 203.0% | 488.3% | 20.3% | 17.0% | 19.9% | 33.8% | -100.0% | 0.0% | |
| Gross Profit | 31563.8% | -109.6% | 137.0% | 3924.8% | 27.2% | 21.9% | 19.9% | 33.8% | -100.6% | 100.0% | |
| Operating Income | 111.4% | -1299.1% | -61.8% | 46.9% | -146.2% | -24.9% | 51.3% | 139.6% | -220.0% | 29.7% | |
| Net Income | 112.8% | -1600.7% | 58.0% | -173.6% | 10.2% | -31.8% | 41.5% | 155.8% | -189.7% | -346.2% | |
| EPS (Diluted) | 111.5% | -1485.7% | 22.2% | 31.3% | -15.8% | 16.8% | 52.2% | 155.9% | -189.5% | 13.8% | |
| Operating Cash Flow | 119.5% | -703.4% | -39.9% | 216.4% | -193.3% | -52.5% | -7.7% | 3.8% | 58.7% | 56.2% | |
| Free Cash Flow | 119.2% | -712.4% | -40.9% | 212.6% | -197.9% | -50.7% | -6.7% | 3.9% | 58.7% | 56.2% | |
| R&D Expense | -46.0% | 135.4% | 89.6% | 5.5% | 103.7% | 23.4% | -38.8% | -68.4% | -76.3% | -96.9% | |
| SG&A Expense | 13.5% | 13.4% | 49.1% | 14.5% | 46.0% | 25.1% | 8.5% | -29.7% | -41.9% | -10.2% | |
| Total Assets | 18.1% | 87.9% | -21.0% | 153.7% | -17.0% | 2.1% | -32.1% | -65.8% | -55.8% | 133.5% | |
| Book Value / Share | 9.4% | -8.3% | -44.9% | 25.6% | -48.0% | -4.2% | -56.1% | 34.1% | -48.7% | -52.6% | |
| Debt | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 16.2% | 32.0% | -100.0% | 0.0% | 0.0% | |
| Diluted Shares | 7.4% | 12.2% | 74.7% | 25.8% | 25.7% | 9.3% | 6.5% | 0.0% | 0.0% | 418.7% |
Valuation
P/E (TTM)At Loss
P/S0.00
10Y Low / Med / High0.37 / 0.71 / 5.77
P/B0.60
10Y Low / Med / High0.17 / 0.54 / 1.78
EV/EBITDA4.90
10Y Low / Med / High0.07 / 0.14 / 1.03
EV/Revenue0.00
10Y Low / Med / High0.01 / 0.53 / 1.33
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$0.16
Tangible Book / Share
$1.71
Net Current Assets / Share
$0.15
Graham Net-Net
$0.18
Cash / Share
$0.13
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | 3.24 | -0.23 | -0.96 | -0.44 | -0.37 | -0.45 | -0.95 | 1.70 | -1.90 | -0.45 | -0.13 | |
| P/S Ratio | 0.37 | 5.77 | 3.28 | 0.71 | 0.73 | 0.69 | 0.62 | 0.46 | 0.00 | 0.00 | 0.00 | |
| P/B Ratio | 0.17 | 0.19 | 0.34 | 0.27 | 0.52 | 0.54 | 1.23 | 0.91 | 1.78 | 0.77 | 0.60 | |
| EV/EBITDA | 0.07 | 0.14 | -0.14 | -0.34 | -0.62 | -0.29 | -0.71 | 1.03 | -0.71 | -2.13 | 4.90 | |
| EV/Revenue | 0.01 | -2.44 | 1.33 | 0.29 | 0.73 | 0.54 | 0.53 | 0.41 | 0.00 | 0.00 | 0.00 |
Analyst Estimates & Quality
Altman Z-Score
0.30
Distress
Piotroski F-Score
1
Weak
Forward Estimates (consensus)
| Metric | FY2027 | FY2028 |
|---|---|---|
| Revenue | $25.0M | $25.0M |
| Net Income | -$53.9M | -$53.9M |
| EPS | $-1.56 | $-1.56 |
| # Analysts (EPS) | 1 | 1 |
Dividends
Frequency
Special
Recent Payments
| Ex-Date | Pay Date | Amount | Frequency |
|---|---|---|---|
| Nov 16, 2023 | Dec 6, 2023 | $1.75 | Special |